SCHEMBL6754273

SCHEMBL6754273

N#CC(N)Cc1cccnc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF20A O95235 1/20 0.48
FDPS P14324 1/20 0.47
CHRNA7 P36544 1/20 0.47
LMNA P02545 1/20 0.45
CYP2A6 P11509 1/20 0.44
CYP2D6 P10635 2/20 0.44
CYP1A2 P05177 2/20 0.44
FPR1 P21462 1/20 0.44
HRH1 P35367 2/20 0.42
CHRNB2 P17787 3/20 0.42
CHRNA4 P43681 3/20 0.42
NAPRT Q6XQN6 1/20 0.41
CYP3A4 P08684 2/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
RECQL P46063 1/20 0.40
CYP2C9 P11712 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2928425 1.00 KIF20A (0.48) KIF20AFDPSCHRNA7LMNACYP2A6
SCHEMBL3756927 0.82 CYP2A6 (0.57) CYP2A6CYP2D6CYP1A2CYP3A4CYP2C9
SCHEMBL694048 0.82 FDPS (0.51) FDPSCHRNA7CYP2A6CYP2D6CYP1A2
SCHEMBL1696723 0.82 FDPS (0.51) FDPSCHRNA7CYP2A6CYP2D6CYP1A2
SCHEMBL2264768 0.82 FDPS (0.51) FDPSCHRNA7CYP2A6CYP2D6CYP1A2
SCHEMBL200084 0.79 FDPS (0.51) KIF20AFDPSCHRNA7LMNACYP2A6
SCHEMBL2927949 0.77 LOXL2 (0.43) CYP2D6CYP1A2HRH1CYP3A4SLC6A2
SCHEMBL6751233 0.77 LOXL2 (0.43) CYP2D6CYP1A2HRH1CYP3A4SLC6A2
SCHEMBL2921309 0.77 EPHX1 (0.56) CYP2A6CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL1598678 0.77 EPHX1 (0.56) CYP2A6CYP2D6SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6759428-B2 SUCH AS N-((1,2)-2-(((CYANO(CYCLOPROPYL)METHYL)AMINO)CARBONYL) CYCLOHEXYL)-1H-INDOLE-2-CARBOXAMIDE; CATHEPSIN K INHIBITORS ROCHE PALO ALTO LLC 2004-07-06 US disclosed
US-20040077646-A1 Indole nitriles ROCHE PALO ALTO LLC 2004-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077646-A1 Indole nitriles TPH1, IDO1, NAT1 KIF20A 3765/4885FDPS 4729/4885CHRNA7 1619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.